Abionyx Pharma SA
PAR:ABNX

Watchlist Manager
Abionyx Pharma SA Logo
Abionyx Pharma SA
PAR:ABNX
Watchlist
Price: 1.658 EUR 4.54%
Market Cap: 57.9m EUR

Intrinsic Value

The intrinsic value of one ABNX stock under the Base Case scenario is 3.193 EUR. Compared to the current market price of 1.658 EUR, Abionyx Pharma SA is Undervalued by 48%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ABNX Intrinsic Value
3.193 EUR
Undervaluation 48%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Abionyx Pharma SA

What is Valuation History?
Compare ABNX to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ABNX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Abionyx Pharma SA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Abionyx Pharma SA

Current Assets 5.9m
Cash & Short-Term Investments 3.2m
Receivables 2.3m
Other Current Assets 329k
Non-Current Assets 7.7m
PP&E 2m
Intangibles 5.5m
Other Non-Current Assets 244k
Efficiency

Free Cash Flow Analysis
Abionyx Pharma SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Abionyx Pharma SA

Revenue
4.6m EUR
Cost of Revenue
-3.7m EUR
Gross Profit
844k EUR
Operating Expenses
-5.3m EUR
Operating Income
-4.5m EUR
Other Expenses
84k EUR
Net Income
-4.4m EUR
Fundamental Scores

ABNX Profitability Score
Profitability Due Diligence

Abionyx Pharma SA's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

26/100
Profitability
Score

Abionyx Pharma SA's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

ABNX Solvency Score
Solvency Due Diligence

Abionyx Pharma SA's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Negative Net Debt
Average Altman Z-Score
63/100
Solvency
Score

Abionyx Pharma SA's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABNX Price Targets Summary
Abionyx Pharma SA

Wall Street analysts forecast ABNX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABNX is 10.965 EUR with a low forecast of 10.1 EUR and a high forecast of 12.075 EUR.

Lowest
Price Target
10.1 EUR
509% Upside
Average
Price Target
10.965 EUR
561% Upside
Highest
Price Target
12.075 EUR
628% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Abionyx Pharma SA
does not pay dividends
Shareholder Yield

Current shareholder yield for ABNX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ABNX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ABNX stock?

The intrinsic value of one ABNX stock under the Base Case scenario is 3.193 EUR.

Is ABNX stock undervalued or overvalued?

Compared to the current market price of 1.658 EUR, Abionyx Pharma SA is Undervalued by 48%.

Back to Top